Figure 2.

Clinical digital photography of the representative subjects. (a) 35-year-old female, baseline TEWL: 541, baseline erythema index: 25.05 (b) TEWL at 2 weeks post treatment was 506 g·h⁻¹·m⁻² (6.5% decreased from baseline) and erythema index at 2 weeks post treatment was 23.90 (4.2% decreased from baseline). (c) TEWL at 6 weeks post treatment was 441 (18.5% decreased from baseline) and erythema index at 6 weeks post treatment was 20.65 (17.6% decreased from baseline). The white dotted circles were the most erythematous parts where the severity of erythema was measured, and they generally coincided with the parts where the patient expressed satisfaction with improvement in erythema.